Intelligence Unit
Special Reports
Special Events
Subscribe/Buy
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
Cost-effectiveness of cancer drugs is questioned
Wall Street Journal, June 30, 2009
The widespread use of expensive cancer drugs to prolong patients’ lives by just weeks or months was called into question by an article published in the Journal of the National Cancer Institute. But while some policy experts consider the rationing of healthcare resources inevitable in the quest to control medical spending, many Americans have long resisted putting the collective fiscal good over their individual health.
Most Viewed
Most Emailed
- CMS Reveals Central Line Infection Rates, Finally
- Keeping Readmission Rates Low with Treatment Guidelines
- 5010 Logjam Means No Pay for Physicians
- Medicare Physician Payment Rule Factors in GPCI
- Leading Change is Tough from the Back of a Limo
- Feds Release Final Rules on Health Plan Language
- Getting to the Heart of Cardiology Alignment
- Engineering a High-Performance Emergency Department
- UnitedHealth will tie doctors' payments to quality of care
- Parkland Keeping Consultant's Analysis Under Wraps
